Jose Miguel S.
- Country
- Spain
- Department
- Oncology department
Research Overview
- A Phase Ib/II, Multi-Center, Open-Label Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Efficacy of GFH925 in Combination with Cetuximab in Previously Untreated Advanced NSCLC Harboring KRAS G12C Mutation
- A Phase III Double-Blind, Placebo-Controlled Study of Adjuvant Durvalumab in Resected Stage IB-IIIA Non-Small Cell Lung Cancer with PD-L1 Expression ≥25%
Data & Insights
Has run more than one trial at 6 of 114 partner sites.
Specializations
Lung Cancer Research
The investigator specializes in treating non-small cell lung cancer, with particular focus on completely resected cases at stages IB, II, and IIIA. Their expertise extends to innovative adjuvant therapeutic approaches for patients with specific molecular characteristics.
- Post-surgical treatment strategies
- PD-L1 expression analysis
- EGFR and ALK mutation assessment
Primary interest lies in improving disease-free survival through targeted immunotherapy approaches in the post-resection setting.
Breast Cancer Studies
The investigator focuses on early-stage invasive breast cancer research, with emphasis on long-term patient outcomes. Their work encompasses comprehensive follow-up studies of neoadjuvant and adjuvant treatment approaches.
- Disease progression patterns
- Relapse monitoring
- Treatment response evaluation
Specialized interest in tracking recurrence patterns and developing enhanced surveillance protocols for early-stage breast cancer patients.
Therapeutic Innovation
The investigator's work centers on advanced therapeutic protocols in oncology, incorporating both established and emerging treatment modalities.
- Adjuvant therapy optimization
- Neoadjuvant treatment approaches
- Long-term outcome assessment
Focus includes evaluating therapeutic efficacy across different cancer stages and molecular profiles.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.